Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|January 31, 2012
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ miceAltaf Mohammed, Li Qian, Naveena B Janakiram, et al.
International Journal of Cancer|February 8, 2023
Combination of naproxen and a chemically-stable eicosapentaenoic acid analog provide additive tumor protection in Pirc ratsRyan Beach, Yuichiro Hatano, Yong Qiao, et al.
Neoplasia (New York, N.Y.)|March 21, 2012
Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) miceNaveena B Janakiram, Altaf Mohammed, Li Qian, et al.
Nutrition and Cancer|November 15, 2008
Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acidsMalisetty V Swamy, Bhargava Citineni, Jagan M R Patlolla, et al.
Carcinogenesis|March 6, 2015
Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient miceHiroshi Y Yamada, Yuting Zhang, Arun Reddy, et al.
Neoplasia (New York, N.Y.)|June 6, 2021
Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras<sup>G12V</sup> miceGaurav Kumar, Venkateshwar Madka, Anil Singh, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 16, 2013
Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicityDoris Mangiaracina Benbrook, Suresh Guruswamy, Yuhong Wang, et al.
Oncotarget|September 17, 2017
Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage <i>in vivo</i>Chinthalapally V Rao, Sanya Pal, Altaf Mohammed, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 13, 2013
Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesisDurgadevi Ravillah, Altaf Mohammed, Li Qian, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA ExpressionRonald A Lubet, Amit Kumar, Jennifer T Fox, et al.
Pageof 8